ストックスクリーナーアプリを入手
0.307
3.58%
-0.0114
プレマーケット:
.32
0.013
+4.23%
前日終値:
$0.3184
開ける：
$0.325
24時間の取引高:
2.91M
Relative Volume:
1.44
時価総額：
$8.00M
収益：
-
当期純損益:
$-16.26M
株価収益率:
-0.2599
EPS:
-1.1814
ネットキャッシュフロー:
$-13.50M
1週間 パフォーマンス:
-7.81%
1か月 パフォーマンス:
+10.83%
6か月 パフォーマンス:
-87.96%
1年 パフォーマンス:
-93.68%
1日の値動き範囲:
$0.306
$0.325
1週間の範囲:
$0.30
$0.3402
52週間の値動き範囲:
$0.2602
$4.9399
Intensity Therapeutics Inc Stock (INTS) Company Profile
名前
Intensity Therapeutics Inc
セクター
電話
203-221-7381
住所
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
INTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.307 | 8.68M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Intensity Therapeutics Inc (INTS) 最新ニュース
What analysts say about Intensity Therapeutics Inc. stockExponential return rates - jammulinksnews.com
What drives Intensity Therapeutics Inc. stock priceExtraordinary market timing - Autocar Professional
Is Intensity Therapeutics Inc. a good long term investmentSky-high profits - jammulinksnews.com
How Intensity Therapeutics Inc. stock performs during market volatilityFree Membership Group - Newser
The Business Case For Buying Intensity Therapeutics Inc (NASDAQ: INTS) Stock Now - Stocksregister
Intensity Therapeutics Inc. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
SBXD.U Stock Analysis and ForecastFree Investment Case Studies - Jammu Links News
Is EUDA a good long term investmentFree Investment Community - Jammu Links News
What drives World Kinect Corporation stock priceRapid portfolio appreciation - Jammu Links News
Intensity Therapeutics shareholders elect director and approve auditor at annual meeting - Investing.com
Intensity Therapeutics Holds Annual Stockholders’ Meeting - TipRanks
Is AFJKU a good long term investmentDynamic investment growth - Jammu Links News
why afloki(angryfloki) will explodeFree Access to Community - Newser
How LGCL stock performs during market volatilityCapital Efficient Investment Tips - Newser
Why BNAIW stock attracts strong analyst attentionFree Investment Community - Newser
How CAMP stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes AACT.WS stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Why Mandatory Common Exchange Trust Preferred Security stock attracts strong analyst attention2x Return Forecast - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser
What makes Capricor Therapeutics Inc. stock price move sharplyDaily Stock Radar - Newser
What makes Intensity Therapeutics Inc. stock price move sharplySmart Money Signals - Newser
Why Herc Holdings Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser
How Apple Hospitality REIT Inc. stock performs during market volatilityFree Group Entry - Newser
Why REXR.PRC stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser
How Ichor Holdings Ltd. stock performs during market volatilityHigh Accuracy Alerts - Newser
How LANDO stock performs during market volatilityTop Growth Low Risk Stocks - Newser
What makes flyExclusive Inc. Equity Warrant stock price move sharplySafe and Smart Investment Picks - Newser
INTS Stock: Exploring Intensity Therapeutics Inc’s Growth - investchronicle.com
OP’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Intensity Therapeutics Inc’s Shares Reel: -85.34% Quarterly Revenue Decline Amid 7.38M Market Cap - investchronicle.com
Intensity Therapeutics Announces $2.3 Million Public Offering of Common Stock - Global Legal Chronicle
Oncology Innovation Just Hit a Turning Point — Here’s What to Watch - The Malaysian Reserve
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch - The Globe and Mail
Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST) - Nasdaq
INTS SEC FilingsINTENSITY THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - The Globe and Mail
Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds - The Globe and Mail
Intensity Therapeutics Inc (INTS) 財務データ
収益
当期純利益
現金流量
EPS
0.51%
大文字化:
|
ボリューム (24 時間):